Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by CERo Therapeutics Holdings, Inc.
CERo Therapeutics, Inc. Announces Financing and Provides Update on Investigational New Drug Application for CER-1236
September 25, 2024
From
CERo Therapeutics Holdings, Inc.
Via
GlobeNewswire
Tickers
CERO
CERo Therapeutics, Inc. Presents CER-1236 Data Supporting Use in AML at Global Cell & Gene Therapy Summit 2024
July 08, 2024
From
CERo Therapeutics Holdings, Inc.
Via
GlobeNewswire
Tickers
CERO
CERo Therapeutics, Inc. Completes IND-Enabling Activities Following Successful Manufacturing Runs for Lead Compound CER-1236
June 13, 2024
From
CERo Therapeutics Holdings, Inc.
Via
GlobeNewswire
Tickers
CERO
CERo Therapeutics, Inc. Successfully Completes IND-Enabling Toxicology Studies for Lead Compound CER-1236
June 06, 2024
From
CERo Therapeutics Holdings, Inc.
Via
GlobeNewswire
Tickers
CERO
CERo Therapeutics, Inc. Provides Corporate Update for Shareholders
May 15, 2024
From
CERo Therapeutics Holdings, Inc.
Via
GlobeNewswire
Tickers
CERO
CERo Therapeutics, Inc. Announces Publication of Preclinical Research Supporting the Use of Its Clinical Candidate CER-1236 to Treat AML Patients
March 07, 2024
From
CERo Therapeutics Holdings, Inc.
Via
Business Wire
Tickers
CERO
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.